M. Tantawy, Mervat I. Abd-Elazeem, Asmaa Mohamed, Rabab Altememy, H. Fathy
{"title":"埃及系统性红斑狼疮患者血清白细胞介素36α水平及其与疾病活动度的关系","authors":"M. Tantawy, Mervat I. Abd-Elazeem, Asmaa Mohamed, Rabab Altememy, H. Fathy","doi":"10.21608/ejmr.2023.218599.1409","DOIUrl":null,"url":null,"abstract":"____________________________________ Background: Systemic lupus erythematosus (SLE) is a systemic illness marked by clinical variability, unpredictable outcome, and recurring flares. Interleukin 36α is crucial for innate immunity. It is strongly hypothesized that IL-36 has an impact on SLE pathogenesis. Aim: Assessing the link between interleukin 36α levels and disease","PeriodicalId":11524,"journal":{"name":"Egyptian Journal of Medical Research","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Interleukin 36α Serum Level in Egyptian Patients with Systemic Lupus Erythematosus and its relation to Disease Activity\",\"authors\":\"M. Tantawy, Mervat I. Abd-Elazeem, Asmaa Mohamed, Rabab Altememy, H. Fathy\",\"doi\":\"10.21608/ejmr.2023.218599.1409\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"____________________________________ Background: Systemic lupus erythematosus (SLE) is a systemic illness marked by clinical variability, unpredictable outcome, and recurring flares. Interleukin 36α is crucial for innate immunity. It is strongly hypothesized that IL-36 has an impact on SLE pathogenesis. Aim: Assessing the link between interleukin 36α levels and disease\",\"PeriodicalId\":11524,\"journal\":{\"name\":\"Egyptian Journal of Medical Research\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Egyptian Journal of Medical Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.21608/ejmr.2023.218599.1409\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Egyptian Journal of Medical Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21608/ejmr.2023.218599.1409","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Interleukin 36α Serum Level in Egyptian Patients with Systemic Lupus Erythematosus and its relation to Disease Activity
____________________________________ Background: Systemic lupus erythematosus (SLE) is a systemic illness marked by clinical variability, unpredictable outcome, and recurring flares. Interleukin 36α is crucial for innate immunity. It is strongly hypothesized that IL-36 has an impact on SLE pathogenesis. Aim: Assessing the link between interleukin 36α levels and disease
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
